Systemic Sclerosis With Lung Involvement research hub

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

This study looks into using mycophenolate mofetil for systemic sclerosis patients with early lung problems. It aims to see if an earlier treatment can help prevent the lung condition from getting worse and test if a larger study is possible.